Mengqing Zhang
Papers
1
Total Citations
4
H-Index
1
About
Dr. Mengqing Zhang is a clinical researcher whose work sits at the intersection of cognitive neuroscience and neurorehabilitation, with a particular focus on aging populations. Her primary research areas include mild cognitive impairment (MCI), dysphagia (swallowing disorders), and non-invasive brain stimulation techniques, specifically intermittent theta burst stimulation (iTBS). Dr. Zhang’s most notable contribution is her pioneering 2025 randomized controlled trial investigating the effects of iTBS on cognitive and swallowing function in patients with MCI and dysphagia risk. This study, which has already garnered 4 citations shortly after publication, is significant for targeting the right dorsal lateral prefrontal cortex (rDLPFC)—a novel approach in this dual-risk population. By addressing the critical gap in early intervention for dementia-related complications, her work provides promising evidence for a non-pharmacological treatment that could improve both cognitive decline and swallowing safety. Dr. Zhang’s research is particularly impactful for clinicians and researchers seeking integrated therapies for neurodegenerative conditions, and her findings are poised to influence future rehabilitation protocols.
Research Focus
Key Achievements
Top Papers
- 1